Chapter 7 Respiratory Drugs - PowerPoint PPT Presentation

1 / 47
About This Presentation
Title:

Chapter 7 Respiratory Drugs

Description:

Inhaled steroids, have localized side effects, such as throat irritation and hoarseness. ... Oral steroids short-term and long-term adverse effects. ... – PowerPoint PPT presentation

Number of Views:294
Avg rating:3.0/5.0
Slides: 48
Provided by: brentm3
Category:

less

Transcript and Presenter's Notes

Title: Chapter 7 Respiratory Drugs


1
Chapter 7 Respiratory Drugs
2
Ventilation
  • Refers to the movement of air in and out of the
    lungs through a series of air passages.
  • Nose
  • Mouth
  • Trachea
  • Bronchial tree
  • The upper portion of the respiratory system is
    mainly responsible for conditioning inhaled air
    from the environment.

3
  • To maintain normal ventilatory function, it is
    critical that the upper respiratory system adjust
    the temperature and humidify the inhaled air as
    well as provide filtration of the contaminants in
    the ambient air.

4
  • Filtration of inspired air occurs mainly as the
    inhaled air passes over the mucus lined
    epithelium of the trachea.
  • The branches of the bronchial tree are lined with
    smooth muscle, which adjusts the constriction and
    dilation of the airways in response to the needs
    of the body.

5
Respiratory System
  • In the respiratory system, receptor specificity
    is a very important issue and has prompted a
    continued development in many of the agents
    discussed in this chapter.

6
  • One of the major systems regulating the
    respiratory system is the autonomic nervous
    system
  • A main function of the autonomic nervous system
    is to regulate smooth muscle tone in the
    respiratory system and thereby maintain the
    balance between bronchoconstriction and
    bronchodilation.

7
Asthma
  • Millions of people in the United States have
    asthma and billions of dollars are spent annually
    on the care of these individuals.
  • Asthma is a condition of the respiratory system
    involving narrowing (bronchoconstriction) and
    inflammation of the small air passages of the
    lower respiratory system.

8
  • Technically, asthma, exercise induced asthma
    (EIA), and exercise induced bronchoconstriction
    (EIB) are separate conditions and treated
    differently.
  • True asthma is characterized by both
    bronchoconstriction and inflammation in the
    respiratory tract.

9
  • Exercise is a trigger for approximately 80 to
    90 of individuals with asthma.
  • Individuals with EIA, must have excellent control
    of their underlying asthma in order to be able to
    prevent asthma exacerbations during physical
    activity

10
  • Exercise-induced bronchoconstriction without
    active inflammation is technically not exercise
    induced asthma.
  • Exercise-induced bronchoconstriction occurs in
    approximately 11 of individuals without asthma
    and the rate may be as high as 50 for elite
    athletes.

11
  • In asthmatic reaction, inflammatory response
    increase in mucus production to protect body
  • Excess coating can lead to air-flow restriction
  • Another mechanism to protect body is
    bronchoconstriction

12
  • The classic signs of an acute asthma exacerbation
    are
  • Shortness of breath
  • Wheezing following exercise
  • Other signs and symptoms include
  • Cough
  • Headache
  • Stomach cramps
  • Pain or tightness in the chest
  • Nausea

13
  • These signs and symptoms typically start 6 to 8
    minutes after the onset of strenuous exercise but
    may not reach maximum severity until up to 15
    minutes after the cessation of exercise.
  • Typically, spontaneous return to baseline
    respiratory function occurs within a 20- to
    60-minute period following onset of symptoms.

14
Asthma Treatment Options
  • Certified athletic trainers often interact with
    athletes who use an inhaler, or more formally
    known as metered dose inhalers (MDIs).
  • Most true asthma exacerbations have both an
    inflammatory and bronchoconstriction component.
  • The use of medications to control and treat
    asthma may address one or both of these problems.

15
  • Currently, the most widely accepted approach to
    asthma treatment is to initially control the
    inflammatory process associated with the trigger
    and thus prevent bronchoconstriction onset.
  • This approach is reflected in the switch from
    heavy dependence on rescue inhalers to the
    increased use of controlling agents.

16
  • With respect to exercise-induced asthma, the
    athlete typically experiences little or no active
    inflammatory process and the primary complication
    is the bronchoconstriction associated with the
    exercise trigger.
  • The treatment for asthma and EIA are different.

17
  • Asthma exacerbations are categorized based on the
    severity and the frequency of the symptoms.
  • In general, asthma is broken down into four
    categories (Table 7-1, pg 95)
  • mild intermittent
  • mild persistent
  • moderate persistent
  • severe persistent

18
Commonly Used Drugs for Asthma Control
  • Numerous pharmacological approaches are used to
    treat asthma.
  • Some factors that influence the choice of
    approach are severity and frequency of the
    exacerbations, as well as the convenience of
    using the drug.
  • The drugs used to treat asthma can be classified
    into two groups
  • bronchodilators and anti-inflammatory agents
    (steroids and non-steroids).

19
  • It is generally accepted that anyone with
    persistent asthma should utilize a controlling
    agent for the inflammatory component in
    conjunction with a rescue inhaler for the
    bronchoconstriction.
  • The role of corticosteroids in asthma, and
    respiratory care in general, is to combat
    inflammation of the airways associated with
    certain respiratory conditions.

20
  • Corticosteroids indirectly prevent
    inflammation-mediated bronchoconstriction through
    the inhibition of prostaglandins and
    leukotrienes.
  • In addition, corticosteroids reverse vascular
    permeability associated with the inflammation
    process.

21
  • Oral nonsteroidal asthma medications are an
    attractive alternative to the use of inhaled
    steroids in the control of asthma.
  • In addition, there is no fluctuation in delivery
    of the medication due to improper use of the MDI.
  • It is important to note that all individuals who
    use either steroids or nonsteroidals still need
    access to a rescue inhaler in the event of an
    asthma exacerbation

22
  • Rescue Inhalers
  • Table 7-2, pg 96
  • Exercise-induced Asthma
  • Causes
  • water loss
  • heat exchange cooling the airways
  • Increased sodium intake
  • Must have formal diagnosis

23
Adverse Effects of Asthma Medications
  • MDIs have less serious adverse effects
  • Localized delivery of the medication
  • The adverse effects of beta-2 agonists are
    relatively minor.
  • Common adverse effects include nervousness,
    restlessness, trembling, throat irritation, and
    potential airway hypersensitivity.

24
  • Inhaled steroids, have localized side effects,
    such as throat irritation and hoarseness.
  • The inhaled steroid residue present in the mouth
    alters the bacterial environment, thus allowing
    for opportunistic yeast infections in the mouth.
  • To limit this problem, users are encouraged to
    rinse their mouth and brush their teeth after
    each use of an inhaler.

25
  • Oral steroids short-term and long-term adverse
    effects.
  • Short term increased appetite, acne, poor wound
    healing, fluid retention, and insomnia
  • Long-term avascular necrosis, osteoporosis,
    glaucoma, and decreased muscle mass

26
  • Adverse effects of inhaled nonsteroidal asthma
    medications
  • Bitter taste in mouth
  • Throat irritation
  • Dry mouth
  • Headache
  • Skin rash

27
Allergies
  • Are the result of some adverse environmental
    stimulus
  • Two classes of drugs are used for the treatment
    of allergies
  • Antihistamines
  • Corticosteroids (nasal sprays).

28
Histamines
  • Histamine causes blood vessel dilation and
    subsequently an inflammatory response in the area
    affected.
  • Results in an inflammatory response noted by the
    classic allergy symptoms, such as runny nose,
    itchy and watery eyes, and sneezing.

29
Antihistamines
  • Antihistamines produce three general effects on
    the body
  • Alteration of histamine action
  • Sedation
  • Anticholinergic activity (decreased salivation,
    dry mouth, and constipation)

30
  • Currently there are first- and second-generation
    antihistamines
  • The major differences between the two generations
    are
  • The time they are active
  • 1st generation 4 to 6 hrs
  • 2nd generation up to 12 hrs
  • The extent to which they promote drowsiness
  • 2nd generation are less sedating

31
  • Antihistamine drugs
  • Halt increased vascular permeability
  • Decrease smooth muscle constriction of the
    airways
  • First-generation antihistamines cross the blood
    brain barrier and cause sedation
  • Use a first-generation antihistamine during the
    evening (less expensive) and nighttime
  • Switch to a second-generation antihistamine
    during the daytime

32
  • Antihistamines result in decreased symptoms and
    increased patient comfort.
  • Their use is sometimes questioned.
  • Impeding these effects is not always a good
    thing.
  • The body produces mucus in an effort to protect
    the respiratory system.
  • Decreasing these functions may slow recovery.

33
  • Antihistamines may not be effective in decreasing
    nasal blockage.
  • Second-generation antihistamines are available
    with a decongestant.
  • Claritin-D and Allegra-D
  • A decongestant will assist with the resolution of
    the runny nose and head congestion.

34
  • Adverse effects of antihistamines
  • Mucous membrane dryness
  • Cardiac stimulation
  • Blurred vision
  • Urinary retention

35
Steroid Nasal Spray
  • Nasal steroid medications are specifically used
    for allergic rhinitis.
  • They are not for symptoms of the common cold.
  • Drugs are delivered locally.
  • Potential for nasal irritation, dryness, and
    epistaxis

36
Coughs and Colds
  • Runny nose, mild sore throat, and watery eyes are
    similar in both the common cold and allergic
    reactions.
  • Common cold refers to a nonbacterial infection of
    the upper respiratory system.

37
Cough and Cold Medications
  • Decongestants
  • vasoconstriction resulting in mucosal drying
  • Antihistamines
  • combat increased histamine nasal congestion and
    mucosal irritation
  • Expectorants
  • facilitate the removal of mucous from the
    respiratory system
  • Antitussives
  • work to suppress coughing

38
  • Medications may contain a combination of
    decongestant, antihistamine, expectorant, and
    antitussive agents
  • Vicks NyQuil contains
  • Acetaminophen
  • Pseudoephedrine, a decongestant,
  • Dextromethorphan, a cough suppressant
  • Antihistamine

39
Decongestants
  • Prolonged use of decongestants
  • Headache
  • Nausea
  • Dry mouth and nose
  • Dizziness
  • Nervousness
  • Prolonged application of nasal spray (topical)
  • Can cause a rebound effect vasodilatation after
    the initial vasoconstriction decreases

40
  • Common decongestants
  • Pseudoephedrine (Sudafed)
  • Tetrahydroziline (Visine)
  • Oxymetazoline (Afrin)

41
Expectorants
  • Cough syrup to relieve the coughing linked to
    cold symptoms
  • Cough syrups can contain
  • Antitussive (cough suppressant)
  • Expectorant (promotes mucus clearance)
  • If the coughing linked with a cold is
    nonproductive, eliminate the nonproductive
    coughing

42
  • Mucus removal produced by the body during the
    common cold needs to be thin and mobile for the
    coughing to be productive.
  • Expectorants are available in two forms
  • Mucolytic
  • Stimulant

43
Antitussives
  • Antitussives suppress the cough.
  • Use a central or a local mechanism.
  • Used for short periods of time.
  • Used to inhibit a cough via a central mechanism.
  • Cough center located in the medulla is targeted.

44
  • Dextromethorphan (DM) is the most common
    ingredient in OTC suppressing agents.
  • Robitussin products, Tylenol cold products, and
    NyQuil medications.
  • Physician can prescribe a narcotic antitussive.
  • Codeine or hydrocodone.
  • Addictive property of narcotics.
  • Duration of the prescription does not exceed 1
    week.

45
Adverse Effects
  • OTC cold and allergy medications relatively show
    few serious adverse effects.
  • Participating in a sport while in a state of
    drowsiness could be dangerous.
  • Antihistamines (1st generation) can result in
    significant drowsiness even after the drugs
    half-life is complete.

46
  • Antihistamines may cause anticholinergic effects
    such as
  • Mucus membrane dryness
  • Cardiac stimulation
  • Decreased gastrointestinal activity
  • Urinary retention
  • Decongestants can promote
  • Excessive drying of the nose and throat
  • Tachycardia and restlessness

47
  • Guaifenesin (cough syrups)
  • Dizziness
  • Headache
  • Nausea
  • Antitussives (Dextromethorphan)
  • Mild dizziness
  • Drowsiness
  • Nausea
  • Stomach cramps
Write a Comment
User Comments (0)
About PowerShow.com